Skip to main content
GENEPLUS
JiChangAn MRD assay boxes in a laboratory setting

Comprehensive Genomic Profiling Based MRD Detection Assay

  • The First MRD Detection Kit in China to Enter the NMPA
  • Special Review Procedure for Innovative Medical Devices

Comprehensive Genomic Profiling Based MRD Detection Assay

Based on results from tissue-based 5688-gene MRD panel testing, our proprietary algorithm selects dominant clonal variants for patient-specific probe design. These probes are combined with tumor-type-specific probes to create a personalized MRD detection panel. By detecting ctDNA mutations in peripheral blood, the solution provides reference information for precise, full-course disease management in patients with solid tumors.

Individualized MRD Monitoring for All Cancer Patients

Tissue-based 5688-gene MRD panel testing
Personalized MRD panel design based on patient-specific markers
Continuous blood-based MRD monitoring
Clinical value of MRD monitoring
Dual-probe design icon

Dual-Probe Design

Combines tumor-type-specific and patient-specific probes for personalized ctDNA monitoring.

High sensitivity and specificity icon

High Sensitivity and Specificity

LoD as low as 0.005% when tracking 20 variants, with analytical specificity >99%.

Broad patient applicability icon

Broad Patient Applicability

At least 5 trackable loci identified in >99% of patients.

Streamlined workflow icon

Streamlined Workflow

Automated variant selection and reporting, with one-click probe ordering for multiple monitoring time points.

MRD Supports Full-Course Management for Patients with Cancer

Full-course MRD management workflow

Product Materials